tetano
Editor, Senior Moderator
J Microbiol
. 2020 Oct;58(10):886-891.
doi: 10.1007/s12275-020-0335-6. Epub 2020 Sep 29.
Development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) thermal inactivation method with preservation of diagnostic sensitivity
Young-Il Kim[SUP] 1 2 [/SUP], Mark Anthony B Casel[SUP] 1 2 [/SUP], Se-Mi Kim[SUP] 1 [/SUP], Seong-Gyu Kim[SUP] 1 [/SUP], Su-Jin Park[SUP] 1 2 [/SUP], Eun-Ha Kim[SUP] 1 2 [/SUP], Hye Won Jeong[SUP] 1 [/SUP], Haryoung Poo[SUP] 3 [/SUP], Young Ki Choi[SUP] 4 5 [/SUP]
Affiliations
Abstract
Various treatments and agents had been reported to inactivate RNA viruses. Of these, thermal inactivation is generally considered an effective and cheap method of sample preparation for downstream assays. The purpose of this study is to establish a safe inactivation method for SARS-CoV-2 without compromising the amount of amplifiable viral genome necessary for clinical diagnoses. In this study, we demonstrate the infectivity and genomic stability of SARSCoV- 2 by thermal inactivation at both 56?C and 65?C. The results substantiate that viable SARS-CoV-2 is readily inactivated when incubated at 56?C for 30 min or at 65?C for 10 min. qRT-PCR of specimens heat-inactivated at 56?C for 30 min or 65?C for 15 min revealed similar genomic RNA stability compared with non-heat inactivated specimens. Further, we demonstrate that 30 min of thermal inactivation at 56?C could inactivate viable viruses from clinical COVID-19 specimens without attenuating the qRT-PCR diagnostic sensitivity. Heat treatment of clinical specimens from COVID-19 patients at 56?C for 30 min or 65?C for 15 min could be a useful method for the inactivation of a highly contagious agent, SARS-CoV-2. Use of this method would reduce the potential for secondary infections in BSL2 conditions during diagnostic procedures. Importantly, infectious virus can be inactivated in clinical specimens without compromising the sensitivity of the diagnostic RT-PCR assay.
Keywords: COVID-19; RT-PCR; SARS-CoV-2; genomic stability; heat inactivation.
. 2020 Oct;58(10):886-891.
doi: 10.1007/s12275-020-0335-6. Epub 2020 Sep 29.
Development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) thermal inactivation method with preservation of diagnostic sensitivity
Young-Il Kim[SUP] 1 2 [/SUP], Mark Anthony B Casel[SUP] 1 2 [/SUP], Se-Mi Kim[SUP] 1 [/SUP], Seong-Gyu Kim[SUP] 1 [/SUP], Su-Jin Park[SUP] 1 2 [/SUP], Eun-Ha Kim[SUP] 1 2 [/SUP], Hye Won Jeong[SUP] 1 [/SUP], Haryoung Poo[SUP] 3 [/SUP], Young Ki Choi[SUP] 4 5 [/SUP]
Affiliations
- PMID: 32989642
- PMCID: PMC7522010
- DOI: 10.1007/s12275-020-0335-6
Abstract
Various treatments and agents had been reported to inactivate RNA viruses. Of these, thermal inactivation is generally considered an effective and cheap method of sample preparation for downstream assays. The purpose of this study is to establish a safe inactivation method for SARS-CoV-2 without compromising the amount of amplifiable viral genome necessary for clinical diagnoses. In this study, we demonstrate the infectivity and genomic stability of SARSCoV- 2 by thermal inactivation at both 56?C and 65?C. The results substantiate that viable SARS-CoV-2 is readily inactivated when incubated at 56?C for 30 min or at 65?C for 10 min. qRT-PCR of specimens heat-inactivated at 56?C for 30 min or 65?C for 15 min revealed similar genomic RNA stability compared with non-heat inactivated specimens. Further, we demonstrate that 30 min of thermal inactivation at 56?C could inactivate viable viruses from clinical COVID-19 specimens without attenuating the qRT-PCR diagnostic sensitivity. Heat treatment of clinical specimens from COVID-19 patients at 56?C for 30 min or 65?C for 15 min could be a useful method for the inactivation of a highly contagious agent, SARS-CoV-2. Use of this method would reduce the potential for secondary infections in BSL2 conditions during diagnostic procedures. Importantly, infectious virus can be inactivated in clinical specimens without compromising the sensitivity of the diagnostic RT-PCR assay.
Keywords: COVID-19; RT-PCR; SARS-CoV-2; genomic stability; heat inactivation.